Beta test rollout. This site is in community QA — please send feature requests, bug reports and data corrections on the Feedback page or on GitHub.

Home
    Disclaimer
    XLR-11 molecular structure

    XLR-11 Stats & Data

    NPS DataHub
    MW329.46
    FormulaC21H28FNO
    CAS1364933-54-9
    IUPAC[1-(5-fluoropentyl)indol-3-yl]-(2,2,3,3-tetramethylcyclopropyl)methanone
    SMILESFCCCCCn1cc(C(=O)C2C(C)(C)C2(C)C)c2ccccc12
    InChIKeyPXLDPUUMIHVLEC-UHFFFAOYSA-N
    Cannabinoids; 2020/2.1 Von Indol Pyrazol und 4-Chinolon abgeleitete Verbindungen; 2021/2.1 Von Indol Pyrazol und 4-Chinolon abgeleitete Verbindungen; 2022/2.1 Von Indol Pyrazol und 4-Chinolon abgeleitete Verbindungen
    Chemical Class Tetramethylcyclopropanoylindole

    Pharmacology

    DrugBank

    Mechanism of Action

    Synthetic indole-derived cannabinoids have become commonly used recreational drugs and continue to be abused despite their adverse consequences. As compounds that were identified early in the epidemic (e.g., naphthoylindoles) have become legally banned, new compounds have appeared on the drug market. Two tetramethylcyclopropyl ketone indoles, UR-144 (1-pentyl-1H-indol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone and XLR-11 [(1-(5-fluoropentyl)-1H-indol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)

    Metabolism

    The knowledge of metabolic profile of synthetic cannabinoids is important for the detection of drugs in urinalysis due to the typical absence or low abundance of parent cannabinoids in human urine. The fungus Cunninghamella elegans has been reported to be a useful tool for metabolism study and thus applicability to synthetic cannabinoid metabolism was examined. In this study, 8-quinolinyl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (5F-PB-22), 8-quinolinyl 1-pentyl-1H-indole-3-carboxylate (PB-22)

    Toxicity

    PubChem

    There have been case reports of acute kidney injury associated with the use of synthetic cannabinoids such as XLR-11. There has also been at least one case of acute cerebral infarction associated with XLR-11 inhalation.

    Experience Report Analysis

    Erowid
    1 Reports
    2012–2012 Date Range
    1 With Age Data

    Demographics

    Gender Distribution

    Age Distribution

    Reports Over Time

    Real-World Dose Distribution

    62K Doses

    From 3 individual dose entries

    ← Back to XLR-11